Europe — EMA
Odyral (Dorzolamide)
Dorzolamide, the active ingredient in Odyral, is a carbonic anhydrase inhibitor presented as a ophthalmic solution for topical eye use.
Request sourcing
What is Dorzolamide?
Dorzolamide, the active ingredient in Odyral, is a carbonic anhydrase inhibitor presented as a ophthalmic solution for topical eye use. It lowers intra‑ocular pressure in patients with ocular hypertension and open‑angle glaucoma. GNH USA supplies Odyral as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
GNH USA supplies Odyral as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Dorzolamide used for?
Dorzolamide is used primarily by the ocular pressure‑reduction pathway in glaucoma care and helps to manage eye conditions.
- Open‑angle glaucoma: reduces the production of aqueous humour to lower intra‑ocular pressure. - Ocular hypertension: helps to decrease eye‑pressure levels when they are elevated without visible damage. - Secondary secondary secondary secondary secondary secondary secondary … - … … … … … … … … … … … … … … … - … … … … … … … … … … … … … … … - … … … … …
What are the side effects of Dorzolamide?
This ... ... … ... ... ...
What precautions apply to Dorzolamide?
...
What does Dorzolamide interact with?
...
